ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DTC Defence Therapeutics Inc

0.518
-0.01 (-1.89%)
31 Jul 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type
Defence Therapeutics Inc TG:DTC Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.01 -1.89% 0.518 0.50 0.536 0.548 0.486 0.548 27,920 22:50:01

Domtar to sell its interest in Norampac to Cascades

05/12/2006 8:21pm

PR Newswire (US)


Defence Therapeutics (TG:DTC)
Historical Stock Chart


From Aug 2019 to Aug 2024

Click Here for more Defence Therapeutics Charts.
TICKER SYMBOL DTC (TSX, NYSE) MONTREAL, Dec. 5 /PRNewswire-FirstCall/ -- Domtar Inc. announced today that it has reached an agreement in principle to sell its 50% interest in Norampac Inc. to Cascades Inc. for a cash consideration of $560 million. Proceeds of the transaction will mainly be used to reduce financing requirements for the recently announced transaction with Weyerhaeuser. "The combination of our packaging assets with Cascades' has been a success for both partners. While we considered our participation in Norampac as a good investment and always supported its growth throughout the years, this interest in Norampac had long been identified as non core to Domtar. The transaction announced today represents another step Domtar is taking to deliver on its strategic plan aimed at becoming a preferred supplier of fine paper products in North America and at monetizing non core assets in an effort to further strengthen its overall financial position," said Raymond Royer, President and Chief Executive Officer. The transaction is subject to the negotiation of definitive agreements as well as the necessary approvals, including that of the regulatory authorities. The transaction is expected to close before the end of the year. DOMTAR IS THE THIRD LARGEST PRODUCER OF UNCOATED FREESHEET PAPER IN NORTH AMERICA. IT IS ALSO A LEADING MANUFACTURER OF BUSINESS PAPERS, COMMERCIAL PRINTING AND PUBLICATION PAPERS, AND TECHNICAL AND SPECIALTY PAPERS. DOMTAR MANAGES ACCORDING TO INTERNATIONALLY RECOGNIZED STANDARDS 18 MILLION ACRES OF FORESTLAND IN CANADA AND THE UNITED STATES, AND PRODUCES LUMBER AND OTHER WOOD PRODUCTS. DOMTAR HAS 8,500 EMPLOYEES ACROSS NORTH AMERICA. THE COMPANY ALSO HAS A 50% INVESTMENT INTEREST IN NORAMPAC INC., THE LARGEST CANADIAN PRODUCER OF CONTAINERBOARD. DATASOURCE: DOMTAR INC. CONTACT: Christian Tardif, Senior Manager, Corporate and Financial Communications, (514) 848-5515, ; Investor Relations: Pascal Bosse, Manager, Investor Relations, (514) 848-5938, ; Source: Daniel Buron, Senior Vice-President and Chief Financial Officer, (514) 848-5234,

Copyright

1 Year Defence Therapeutics Chart

1 Year Defence Therapeutics Chart

1 Month Defence Therapeutics Chart

1 Month Defence Therapeutics Chart

Your Recent History

Delayed Upgrade Clock